Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4608Pancreatic Neoplasms 2846Carcinoma, Hepatocellular 2483Stomach Neoplasms 2331Colonic Neoplasms 1791Rectal Neoplasms 1720Esophageal Neoplasms 1376Liver Neoplasms 921Neoplasms 917Breast Neoplasms 839Neoplasm Metastasis 765Carcinoma, Non-Small-Cell Lung 708Cholangiocarcinoma 592Lung Neoplasms 557Ovarian Neoplasms 537Esophageal Squamous Cell Carcinoma 514Gastrointestinal Neoplasms 495Melanoma 382Prostatic Neoplasms 374Biliary Tract Neoplasms 374Head and Neck Neoplasms 304Uterine Cervical Neoplasms 289Carcinoma, Renal Cell 286Adenocarcinoma Of Esophagus 273Squamous Cell Carcinoma of Head and Neck 264Sarcoma 264Gastrointestinal Stromal Tumors 252Endometrial Neoplasms 237Gallbladder Neoplasms 227Urinary Bladder Neoplasms 226

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Small Bowel Adenocarcinoma × Gastrointestinal × Clear all
NCT06835387 2026-06-04

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Hoosier Cancer Research Network

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Small Bowel Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡